Evidence map›Paper›PMID 25605764›Full record

ArticleInfection and immunity2015

Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.

Bethany L Tiner, Jian Sha, Michelle L Kirtley, Tatiana E Erova, Vsevolod L Popov, Wallace B Baze, Christina J van Lier, Duraisamy Ponnusamy, Jourdan A Andersson, Vladimir L Motin and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Zoonoses (Shannon, Ireland) · 2023
    Article
  6. Review
  7. Article
  8. Plague vaccines: new developments in an ongoing search.Applied microbiology and biotechnology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Impact of Gentamicin Concentration and Exposure Time on IntracellularFrontiers in cellular and infection microbiology · 2017
    Article
  13. Identification of New Virulence Factors and Vaccine Candidates forFrontiers in cellular and infection microbiology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Protective Immunity Elicited by Oral Immunization of Mice withFrontiers in cellular and infection microbiology · 2016
    Article
  18. Plague Vaccines: Status and Future.Advances in experimental medicine and biology · 2016
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bethany L TinerDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Jian ShaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA jisha@utmb.edu achopra@utmb.edu.
Michelle L KirtleyDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Tatiana E ErovaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Vsevolod L PopovDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Wallace B BazeDepartment of Veterinary Sciences, University of Texas M. D. Anderson Cancer Center, Bastrop, Texas, USA.
Christina J van LierDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Duraisamy PonnusamyDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Jourdan A AnderssonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Vladimir L MotinDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, USA Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, USA.
Sadhana ChauhanDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Ashok K ChopraDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, USA Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, USA jisha@utmb.edu achopra@utmb.edu.
The University of Texas Medical Branch at Galveston · USThe University of Texas MD Anderson Cancer Center · US

Funding

Health, Safety and Training ServicesUC7AI070083 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LEMON, STANLEY M. · 2006 to 2010
$49.5M
Identification of New Antigens for a Plague VaccineR01AI064389 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CHOPRA, ASHOK K · 2005 to 2015
$3.8M
NIAID NIH HHS AI064389NIAID NIH HHS N01 AI030065NIAID NIH HHS N01-AI-30065NIAID NIH HHS R01 AI064389NIAID NIH HHS UC7 AI070083
6 · The paper itself

Abstract

Previously, we showed that deletion of genes encoding Braun lipoprotein (Lpp) and MsbB attenuated Yersinia pestis CO92 in mouse and rat models of bubonic and pneumonic plague. While Lpp activates Toll-like receptor 2, the MsbB acyltransferase modifies lipopolysaccharide. Here, we deleted the ail gene (encoding the attachment-invasion locus) from wild-type (WT) strain CO92 or its lpp single and Δlpp ΔmsbB double mutants. While the Δail single mutant was minimally attenuated compared to the WT bacterium in a mouse model of pneumonic plague, the Δlpp Δail double mutant and the Δlpp ΔmsbB Δail triple mutant were increasingly attenuated, with the latter being unable to kill mice at a 50% lethal dose (LD50) equivalent to 6,800 LD50s of WT CO92. The mutant-infected animals developed balanced TH1- and TH2-based immune responses based on antibody isotyping. The triple mutant was cleared from mouse organs rapidly, with concurrent decreases in the production of various cytokines and histopathological lesions. When surviving animals infected with increasing doses of the triple mutant were subsequently challenged on day 24 with the bioluminescent WT CO92 strain (20 to 28 LD50s), 40 to 70% of the mice survived, with efficient clearing of the invading pathogen, as visualized in real time by in vivo imaging. The rapid clearance of the triple mutant, compared to that of WT CO92, from animals was related to the decreased adherence and invasion of human-derived HeLa and A549 alveolar epithelial cells and to its inability to survive intracellularly in these cells as well as in MH-S murine alveolar and primary human macrophages. An early burst of cytokine production in macrophages elicited by the triple mutant compared to WT CO92 and the mutant's sensitivity to the bactericidal effect of human serum would further augment bacterial clearance. Together, deletion of the ail gene from the Δlpp ΔmsbB double mutant severely attenuated Y. pestis CO92 to evoke pneumonic plague in a mouse model while retaining the required immunogenicity needed for subsequent protection against infection.

Indexed as

AcyltransferasesAnimalsAnti-Bacterial AgentsAntibodies, BacterialBacterial AdhesionBacterial Outer Membrane ProteinsCell LineDisease Models, AnimalDrug Resistance, BacterialFemaleGene DeletionGentamicinsHeLa CellsHumansIntracellular SpaceLipoproteinsAcyltransferasesAil protein, Yersinia pestisAnti-Bacterial AgentsAntibodies, BacterialBacterial Outer Membrane ProteinsGentamicinsLipoproteinsVirulence Factors

Identifiers

PMID25605764
PMCPMC4363438
OpenAlexW2118793623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.